J 2023

Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea

VANEK, Jakub, Jan PRASKO, Samuel GENZOR, Kamila BELOHRADOVA, Jozef VISNOVSKY et. al.

Basic information

Original name

Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea

Authors

VANEK, Jakub (203 Czech Republic), Jan PRASKO (203 Czech Republic, guarantor), Samuel GENZOR (203 Czech Republic), Kamila BELOHRADOVA (203 Czech Republic), Jozef VISNOVSKY (203 Czech Republic), Jan MIZERA (203 Czech Republic), Jonas BOCEK (203 Czech Republic), Milan SOVA (203 Czech Republic, belonging to the institution) and Marie OCISKOVA (203 Czech Republic)

Edition

Psychology Research and Behavior Management, ALBANY, DOVE MEDICAL PRESS LTD, 2023, 1179-1578

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30203 Respiratory systems

Country of publisher

New Zealand

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.300 in 2022

RIV identification code

RIV/00216224:14110/23:00133291

Organization unit

Faculty of Medicine

UT WoS

001019850700001

Keywords in English

obstructive sleep apnoea; depression; cognitive functions; CPAP treatment; treatment efficacy; Trail Making Test; Verbal; Fluency Test

Tags

Tags

International impact, Reviewed
Změněno: 29/1/2024 12:42, Mgr. Tereza Miškechová

Abstract

V originále

Objective: The study worked with depressive symptoms, anxiety score and cognitive functions in obstructive sleep apnea (OSA) patients treated with CPAP.Methods: Eighty-one subjects with OSA and without psychiatric comorbidity were treated with CPAP for one year and completed the following scales and cognitive tests: Trail Making Test, Verbal Fluency Test, d2 Test, Beck Depression Inventory-II and Beck Anxiety Inventory. MINI ruled out psychiatric disorder. At the two months check-up, subjects were re-evaluated for depressive and anxiety symptoms, and after one year of CPAP treatment, subjects repeated cognitive tests and scales. Data about therapy adherence and effectiveness were obtained from the patient's CPAP machines. Results: The study was completed by 59 CPAP adherent patients and eight non-adherent patients. CPAP therapy effectiveness was verified in all patients by decreasing the apnea-hypopnoea index below 5 and/or 10% of baseline values. The adherent patients significantly improved depressive and anxiety symptoms. There was also an improvement in overall performance in the attention test; however, performance in many individual items did not change. The adherent patients also improved verbal fluency and in the Part B of the Trail making test. The non-adherent group significantly increased the number of mistakes made in the d2 test; other resultsConclusion: According to our results, OSA patients' mood, anxiety and certain cognitive domains improved during the one-year therapy with CPAP.